Axcelis Technologies, Inc. — Q3 2014 Form 10-Q
Business context and period: Axcelis makes ion implantation and other semiconductor-processing equipment and provides aftermarket parts and services. This unaudited filing covers the quarter and nine months ended September 30, 2014; comparisons are with the corresponding 2013 periods. Management described a semiconductor-industry spending pause that began in Q2 2014 and continued through Q3.
Financial performance and position
| Metric | Q3 2014 | Q3 2013 | Nine months 2014 | Nine months 2013 |
|---|---|---|---|---|
| Revenue | $38.5m | $48.8m | $140.5m | $137.1m |
| Gross profit / margin | $15.1m / 39.3% | $17.0m / 34.8% | $51.4m / 36.6% | $46.7m / 34.1% |
| Operating loss | $(5.4)m | $(2.8)m | $(11.1)m | $(15.7)m |
| Net loss | $(4.7)m | $(4.8)m | $(11.4)m | $(17.8)m |
| Basic and diluted loss per share | $(0.04) | $(0.04) | $(0.10) | $(0.16) |
| Operating cash flow | Not presented quarterly | $(13.8)m | $(10.8)m |
- Q3 revenue declined 21.1%, principally because product revenue fell 24.6% amid muted customer spending. Systems revenue was $8.4m, versus $20.2m; aftermarket revenue was $30.1m, up $1.5m.
- Nine-month revenue increased 2.5%: product revenue rose 3.4%, while services revenue fell 2.9%. Systems revenue was $51.8m, versus $49.6m; aftermarket revenue was $88.8m, approximately flat year over year.
- Gross margin improved in both comparative periods. Product margins increased, while nine-month service margin declined to 15.5% from 18.4%.
- Q3 operating loss widened despite better gross margin, reflecting $2.3m of restructuring charges versus $0.1m a year earlier. Q3 net loss was nearly unchanged in part because other income was $1.1m, compared with $1.4m of other expense in 2013; management attributed the improvement primarily to foreign-exchange gains. Nine-month net loss narrowed.
- Cash and cash equivalents were $32.5m at September 30, 2014, down from $46.3m at December 31, 2013. Nine-month operating cash use was $13.8m; investing cash use was $0.7m, mainly capital expenditures, and financing provided $2.1m, primarily from option exercises.
- Current assets were $176.0m and current liabilities $31.7m. Inventory was $107.8m, up from $95.8m at year-end. Long-term debt was $13.7m and current debt $1.2m; the term loan bears 5.5% interest. The company reported $8.9m of available capacity under its $10m receivables-based credit facility and no borrowings on it.
Outlook, commentary, risks and unusual items
- Management expected industry conditions to begin improving in Q4 2014 and continue into 2015, while warning that growth could vary from quarter to quarter. It expected to grow Purion platform system sales; the first Purion H shipped in Q2 and a second in Q3. These are forward-looking expectations, not guaranteed results. The filing provides no specific revenue or earnings guidance.
- Management said current cash, cash equivalents and borrowing capacity were expected to meet anticipated short- and long-term cash requirements, based on its forecasts. However, operating cash use increased year over year, and the business is exposed to cyclical customer capital spending.
- On October 3, 2014, after quarter-end, Axcelis agreed to sell its Beverly headquarters for $50m cash, subject to due diligence and other closing conditions, while retaining adjacent acreage. The company expected financing-arrangement accounting, with the property remaining on its books and a $50m financing obligation recorded. The proposed 22-year lease starts at $4.5m annual rent for three years, then $5.0m in year four, with 2.5% annual increases thereafter. Closing would also entail a $5m letter-of-credit security deposit and repayment of the existing mortgage, including a 2% prepayment penalty.
- Loan covenants had been amended or waived after prior-period noncompliance; Axcelis said it was compliant with both facilities at September 30. The term-loan net-income-to-debt-service covenant was deferred to December 31, 2014.
- Customer concentration remained significant: the ten largest customers generated 68.0% of nine-month revenue. Two customers represented 27.1% and 14.8% of accounts receivable at quarter-end. Management reported no litigation it believed would materially harm operations and no material change to previously disclosed risk factors.
- Restructuring charges for the first nine months were $2.6m; $1.4m remained accrued at quarter-end and was expected to be paid primarily in Q4. U.S. tax-loss benefits remained subject to a full valuation allowance.
Important facts for investors to verify
- Whether the headquarters transaction closes, its final terms and conditions, and the resulting financing, rent and liquidity obligations.
- Whether the expected semiconductor-market recovery and Purion sales growth materialize, particularly after the Q2–Q3 spending pause.
- Cash-burn trends, inventory conversion, and the company’s ability to maintain liquidity while operating at a loss.
- Compliance with amended loan covenants, available borrowing capacity and any effect of the real-estate transaction on secured debt.
- Customer concentration and the sensitivity of revenue and service demand to semiconductor-factory utilization and capital spending.